Prevalence of macro- and microvascular complications in patients with type 2 diabetes and kidney disease with or without albuminuria in a single Chinese Diabetes Centre

Diabetes and Vascular Disease Research

Volumn 13, Issue 1, 2016, Pages 21-30

  Wu, Dingting ^a   Xuan, Yanyan ^b   Ruan, Yu ^c   Feng, Xiaocheng ^c   Zhu, Yinchao ^d   Jia, Chengfang ^c   Liu, Jun ^c   Li, Hong ^c   Li, Lianxi ^e   Dong, Xuehong ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NINGBO FIRST HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d NINGBO MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

albuminuria; ankle brachial index; Chronic kidney disease; diabetic neuropathy; diabetic retinopathy

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; AGED; ALBUMINURIA; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; CHINA; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SEX; SMOKING; CASE CONTROL STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

ADULT; AGED; ALBUMINURIA; ANKLE BRACHIAL INDEX; CASE-CONTROL STUDIES; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84950341832     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164115610247     Document Type: Article

References (34)

1. Ritz E, Rychlik I, Locatelli F, et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999; 34: 795-808.
2. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815-822.
3. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225-232.
4. Murussi M, Baglio P, Gross JL, et al. Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study. Diabetes Care 2002; 25: 1101-1103.
5. Gall MA, Hougaard P, Borch-Johnsen K, et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997; 314: 783-788.
6. Mogensen CE,. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999; 42: 263-285.
7. Macisaac RJ, Jerums G,. Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens 2011; 20: 246-257.
8. Retnakaran R, Cull CA, Thorne KI, et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006; 55: 1832-1839.
9. Kramer HJ, Nguyen QD, Curhan G, et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289: 3273-3277.
10. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, et al. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004; 27: 195-200.
11. Thomas MC, Macisaac RJ, Jerums G, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment co-existing with NIDDM [NEFRON] 11). Diabetes Care 2009; 32: 1497-1502.
12. Ninomiya T, Perkovic V, de Galan BE, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009; 20: 1813-1821.
13. Drury PL, Ting R, Zannino D, et al. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 2011; 54: 32-43.
14. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197-208.
15. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109: 733-739.
16. Dong X, Wu D, Jia C, et al. Low ankle-brachial index is associated with early-stage chronic kidney disease in type 2 diabetic patients independent of albuminuria. PLoS ONE 2014; 9: e109641.
17. Yokoyama H, Sone H, Oishi M, et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2009; 24: 1212-1219.
18. Ito H, Takeuchi Y, Ishida H, et al. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria. Nephrol Dial Transplant 2010; 25: 1161-1167.
19. Bancha Satirapoj SA,. Comprehensive approach to diabetic nephropathy. Kidney Res Clin Practice 2014; 33: 121-131.
20. Pugliese G, Solini A, Bonora E, et al. Chronic kidney disease in type 2 diabetes: lessons from the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicentre Study. Nutr Metab Cardiovasc Dis 2014; 24: 815-822.
21. Solini A, Penno G, Bonora E, et al. Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Diabetes Care 2012; 35: 143-149.
22. American Diabetes Association. (8) Cardiovascular disease and risk management. Diabetes Care 2015; 38 (Suppl.): S49-S57.
23. Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol 2004; 88: 920-924.
24. Scanlon PH, Foy C, Malhotra R, et al. The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening. Diabetes Care 2005; 28: 2448-2453.
25. Guidelines in electrodiagnostic medicine. American Association of Electrodiagnostic Medicine. Muscle Nerve 1992; 15: 229-253.
26. Standards of medical care in diabetes-2007. Diabetes Care 2007; 30 (Suppl. 1): S4-S41.
27. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
28. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-e654.
29. Bosman DR, Winkler AS, Marsden JT, et al. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001; 24: 495-499.
30. Ekinci EI, Jerums G, Skene A, et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care 2013; 36: 3620-3626.
31. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462.
32. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
33. Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878.
34. Xie Q, Hao CM, Ji L, et al. ACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study). PLoS ONE 2015; 10: e116970.